Skip to main content
OpenTrials

Clinical trial condition

Glomerulosclerosis, Focal Segmental

Explore clinical trials studying Glomerulosclerosis, Focal Segmental. Study availability and eligibility vary by location and protocol.

80 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Glomerulosclerosis, Focal Segmental trial results

Completed

Kidney Disease Biomarkers

NCT00255398

Conditions
Collapsing Glomerulopathy, Diabetes Complications, Diabetes Mellitus, +22 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details
Completed

Vitamin D Supplementation in Glomerular Disease

NCT01835639

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • Nemours/Alfred I. duPont Hospital for Children Wilmington, Delaware, United States
  • Johns Hopkins University,Division of Pediatric Nephrology Baltimore, Maryland, United States
  • North Shore-Long Island Jewish Health System New Hyde Park, New York, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Evaluation of Albuminuria HIV-Infected Patients

NCT00524992

Conditions
Albuminuria, Blood-Borne Infections, Communicable Diseases, +40 more
Locations
  • Washington Hospital Center Washington D.C., District of Columbia, United States
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details
Completed

Podocyte Retinoids

NCT00098020

Conditions
Chronic Disease, Collapsing Glomerulopathy, Disease Attributes, +20 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details
Completed

A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)

NCT02000440

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Glomerulonephritis, +8 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Stanford, California, United States
  • GSK Investigational Site New Orleans, Louisiana, United States
  • GSK Investigational Site Ann Arbor, Michigan, United States
View Trial Details

Related conditions